Schizophrenia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Schizophrenia stocks.

Schizophrenia Stocks Recent News

Date Stock Title
Jul 1 LLY Lilly in deal with Radionetics Oncology on radiopharmaceuticals development
Jul 1 AZN AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines Agency Accepts Marketing Application Under Accelerated Assessment
Jul 1 NBIX FDA sets target action dates for Neurocrine drug applications
Jul 1 LLY Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
Jul 1 LLY Eli Lilly Soars To 52-Week High: Can The Momentum Continue?
Jul 1 VNDA Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex
Jul 1 LLY Nvidia Among Biggest Stock Market Winners In 2024, But This Is No. 1
Jul 1 LLY Eli Lilly & Co (NYSE:LLY): Jim Cramer’s Best Weight Loss Stock Pick for 2024
Jul 1 LLY Want Decades of Passive Income? 2 Top Dividend Stocks to Buy Now and Hold Forever.
Jul 1 LLY Atossa Therapeutics updates protocol for breast cancer treatment trial
Jul 1 AZN AstraZeneca COVID prevention antibody gets EU fast-track review
Jul 1 LLY 10 clinical trials to watch in the second half of 2024
Jul 1 AZN Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
Jul 1 LLY Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
Jun 30 LLY 5 Reasons Eli Lilly Just Keeps Rising
Jun 30 LLY 2 Top Healthcare Stocks to Buy in June
Jun 30 LLY 3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics
Jun 29 LLY The Top Country With Most Scientists per Capita in the World
Jun 29 LLY This Is Massive News for Eli Lilly Investors
Jun 29 LLY Eli Lilly Is Teaming Up With OpenAI. Here Are 3 Things Smart Investors Should Know.
Schizophrenia

Schizophrenia is a mental disorder characterized by abnormal behavior, strange speech and a decreased ability to understand reality. Other symptoms include false beliefs, unclear or confused thinking, hearing voices that do not exist, reduced social engagement and emotional expression and lack of motivation. People with schizophrenia often have additional mental health problems such as anxiety, depressive or substance-use disorders. Symptoms typically come on gradually, begin in young adulthood and in many cases never resolve.The causes of schizophrenia include environmental and genetic factors. Possible environmental factors include being raised in a city, cannabis use during adolescence, certain infections, the age of a person's parents, and poor nutrition during pregnancy. Genetic factors include a variety of common and rare genetic variants. Diagnosis is based on observed behavior, the person's reported experiences and reports of others familiar with the person. During diagnosis, a person's culture must also be taken into account. As of 2013, there is no objective test. Schizophrenia does not imply a "split personality" or dissociative identity disorder, conditions with which it is often confused in public perception.The mainstay of treatment is antipsychotic medication, along with counselling, job training and social rehabilitation. It is unclear whether typical or atypical antipsychotics are better. In those who do not improve with other antipsychotics, clozapine may be tried. In more serious situations where there is risk to self or others, involuntary hospitalization may be necessary, although hospital stays are now shorter and less frequent than they once were.About 0.3% to 0.7% of people are affected by schizophrenia during their lifetimes. In 2013, there were an estimated 23.6 million cases globally. Males are more often affected and on average experience more severe symptoms. About 20% of people eventually do well, and a few recover completely; about 50% have lifelong impairment. Social problems, such as long-term unemployment, poverty and homelessness, are common. The average life expectancy of people with the disorder is 10–25 years less than that of the general population. This is the result of increased physical health problems and a higher suicide rate (about 5%). In 2015, an estimated 17,000 people worldwide died from behavior related to, or caused by, schizophrenia.

Browse All Tags